Effects of Triptorelin When Given Every 6-months Under the Skin to Adult Males With Cancer in the Prostate
NCT05458856
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
147
Enrollment
INDUSTRY
Sponsor class
Conditions
Prostate Cancer
Interventions
DRUG:
Triptorelin embonate 22.5 mg
Sponsor
Ipsen